Synergistic Effect and Mechanism of Plumbagin with Gentamicin Against Carbapenem-Resistant Klebsiella pneumoniae

References

• Zhang Y, Jin L, Ouyang P, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother. 2020;75(2):327–336. doi:10.1093/jac/dkz44631713615
   PubMed Web of Science ®Google Scholar
• Guo X, Cao Z, Dai Z, et al. Antimicrobial susceptibility and molecular epidemiology of multidrug-resistant klebsiella pneumoniae in central China. Jpn J Infect Dis. 2017;70(3):229–234. doi:10.7883/yoken.JJID.2016.04927580572
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-329276051
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Klee BO, Bulitta JB. Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility. Expert Rev Anti Infect Ther. 2017;15(6):519–526. doi:10.1080/14787210.2017.131619328375030
   PubMed Web of Science ®Google Scholar
• McKinnell JA, Dwyer JP, Talbot GH, et al. Plazomicin for infections caused by carbapenem-resistant Enterobacteriaceae. N Engl J Med. 2019;380(8):791–793. doi:10.1056/NEJMc180763430786196
   PubMed Web of Science ®Google Scholar
• Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 2011;473(7346):216–220. doi:10.1038/nature1006921562562
   PubMed Web of Science ®Google Scholar
• Peng B, Su YB, Li H, et al. Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria. Cell Metab. 2015;21(2):249–262. doi:10.1016/j.cmet.2015.01.00825651179
   PubMed Web of Science ®Google Scholar
• Deng W, Fu T, Zhang Z, et al. L-lysine potentiates aminoglycosides against via regulation of proton motive force and antibiotics uptake. Emerg Microbes Infect. 2020;9(1):639–650. doi:10.1080/22221751.2020.174061132192413
   PubMed Web of Science ®Google Scholar
• Ayaz M, Ullah F, Sadiq A, et al. Synergistic interactions of phytochemicals with antimicrobial agents: potential strategy to counteract drug resistance. Chem Biol Interact. 2019;308:294–303. doi:10.1016/j.cbi.2019.05.05031158333
   PubMed Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163–175. doi:10.1038/nprot.2007.52118274517
   PubMed Web of Science ®Google Scholar
• Díez C, Guillarme D, Staub Spörri A, et al. Aminoglycoside analysis in food of animal origin with a zwitterionic stationary phase and liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2015;882:127–139. doi:10.1016/j.aca.2015.03.05026043099
   PubMed Web of Science ®Google Scholar
• Yao L, Zhou F, Cai M, et al. Development and validation of a sensitive LC-MS/MS method without derivatization/ion-pairing agents for etimicin quantification in rat plasma, internal ear and kidney. J Pharm Biomed Anal. 2017;146:96–102.28881316
   PubMed Web of Science ®Google Scholar
• Maifiah MH, Creek DJ, Nation RL, et al. Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii. Sci Rep. 2017;7:45527. doi:10.1038/srep4552728358014
   PubMed Web of Science ®Google Scholar
• Qian W, Kang A, Peng L, et al. Gas chromatography-mass spectrometry based plasma metabolomics of H1N1-induced inflammation in mice and intervention with Flos Lonicerae Japonica-Fructus Forsythiae herb pair. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1092:122–130. doi:10.1016/j.jchromb.2018.05.047
   Web of Science ®Google Scholar
• Kind T, Wohlgemuth G, Lee DY, et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem. 2009;81(24):10038–10048. doi:10.1021/ac901952219928838
   PubMed Web of Science ®Google Scholar
• Sheu CC, Chang YT, Lin SY, et al. Infections caused by carbapenem-resistant: an update on therapeutic options. Front Microbiol. 2019;10:80. doi:10.3389/fmicb.2019.0008030761114
   PubMed Web of Science ®Google Scholar
• Periasamy H, Iswarya S, Pavithra N, et al. In vitro antibacterial activity of plumbagin isolated from Plumbago zeylanica L. against methicillin-resistant Staphylococcus aureus. Lett Appl Microbiol. 2019;69(1):41–49. doi:10.1111/lam.1316031044446
   PubMed Web of Science ®Google Scholar
• Gupta P, Sarkar A, Sandhu P, et al. Potentiation of antibiotic against Pseudomonas aeruginosa biofilm: a study with plumbagin and gentamicin. J Appl Microbiol. 2017;123(1):246–261. doi:10.1111/jam.1347628429871
   PubMed Web of Science ®Google Scholar
• Taber HW, Mueller JP, Miller PF, et al. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev. 1987;51(4):439–457. doi:10.1128/MMBR.51.4.439-457.19873325794
   PubMedGoogle Scholar
• Padhye S, Dandawate P, Yusufi M, et al. Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev. 2012;32(6):1131–1158. doi:10.1002/med.2023523059762
   PubMed Web of Science ®Google Scholar
• Sumsakul W, Plengsuriyakarn T, Na-Bangchang K. Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin. BMC Pharmacol Toxicol. 2016;17(1):50. doi:10.1186/s40360-016-0094-527839515
   PubMed Web of Science ®Google Scholar
• Roy A, Bharadvaja N. Biotechnological approaches for the production of pharmaceutically important compound: plumbagin. Curr Pharm Biotechnol. 2018;19(5):372–381. doi:10.2174/138920101966618062914384229956626
   PubMed Web of Science ®Google Scholar
• Rajalakshmi S, Vyawahare N, Pawar A, et al. Current development in novel drug delivery systems of bioactive molecule plumbagin. Artif Cells Nanomed Biotechnol. 2018;46(sup1):209–218. doi:10.1080/21691401.2017.141786529298523
   PubMed Web of Science ®Google Scholar